MRI检测乏脂性肾血管平滑肌脂肪瘤的诊断效能:系统评价与Meta分析
该系统评价纳入23项研究、2196例患者,评估MRI以组织病理学为参考标准诊断乏脂性肾血管平滑肌脂肪瘤的效能,合并敏感度83%、特异度90%、AUC 0.93,提示MRI在特定患者中有望替代活检,但所有研究指数测试域存在高偏倚风险。
要点
- MRI诊断乏脂性血管平滑肌脂肪瘤合并敏感度83%、特异度90%、AUC 0.93。
- 所有研究因未预设阈值在指数测试域存在高偏倚风险。
- 亚组分析未发现MRI序列或场强是异质性来源。
核心结论
- MRI对乏脂性血管平滑肌脂肪瘤显示较好的诊断准确度(AUC>0.9),提示在特定患者中可能作为活检的替代检查。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE、EMBASE、Scopus、Cochrane图书馆及灰色文献(会议论文集),无语言限制,截至2019年7月18日。
- 纳入原始文章需评估MRI诊断效能、以组织病理学为参考标准、患者数>10例。
- 排除含宏观脂肪的血管平滑肌脂肪瘤研究及数据不足的研究。
- 共纳入23项研究、2196例患者、25个列联表,采用随机效应或双变量混合效应回归模型进行Meta分析。
诊断标准与关键数值
- 合并敏感度83%(95%CI:72%,90%),特异度90%(95%CI:84%,94%),AUC 0.93(95%CI:0.91,0.95)。
- 采用QUALITY ASSESSMENT OF DIAGNOSTIC ACCURACY STUDIES-2评估偏倚风险,所有研究在指数测试域因未预设阈值均存在高偏倚风险。
- 多个变量存在较大异质性,但亚组分析未发现MRI序列或场强是变异来源。
临床应用与阅片要点
- 作者认为MRI在特定患者中可能作为活检的替代检查,但需采用实用算法和预设阈值的研究来确认其在诊疗路径中的潜在作用。
局限性
- 所有研究在指数测试域存在高偏倚风险,因未报告预设阈值。
- 多个变量存在较大异质性,包括MRI参数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Lipid-poor angiomyolipomas (AMLs) are challenging to differentiate from other renal lesions at imaging and often necessitate biopsy or surgery. If sufficiently accurate, MRI may play a role as a replacement test for biopsy. Purpose To perform a systematic review to evaluate the diagnostic performance of MRI for lipid-poor AMLs in patients with renal masses. Materials and Methods A systematic review of MEDLINE, EMBASE, Scopus, the Cochrane Library, and the "gray literature" (conference proceedings) was performed without language restriction through July 18, 2019, with the assistance of a health sciences librarian. Original articles with more than 10 patients evaluating the diagnostic performance of MRI, with histopathologic findings used as the reference standard, for the diagnosis of lipid-poor AMLs in patients with renal masses were included. Studies including AMLs with macroscopic fat and studies with insufficient data were excluded. Patient, clinical, MRI, and diagnostic performance parameters were independently acquired by two authors. Meta-analysis was performed by using a random-effects or bivariate mixed-effects regression model depending on the number of studies. Risk of bias of individual studies was evaluated by using Quality Assessment of Diagnostic Accuracy Studies-2. Results Twenty-three studies with 2196 patients and 25 contingency tables were included. The pooled sensitivity, specificity, and area under the receiver operating characteristic curve were 83% (95% confidence interval [CI]: 72%, 90%), 90% (95% CI: 84%, 94%), and 0.93 (95% CI: 0.91, 0.95), respectively. Considerable variability was present for several variables, including MRI parameters; however, subgroup analysis did not identify MRI sequence or field strength as sources for variability. All studies were at high risk of bias for index test domain because no reported thresholds were prespecified. Conclusion MRI shows promising accuracy for detecting lipid-poor angiomyolipomas (area under the receiver operating characteristic curve, >0.9), indicating a potential role as a replacement test for biopsy in selected patients. Studies evaluating MRI accuracy with a pragmatic algorithm and prespecified threshold may be helpful to confirm this potential role in the management pathway. © RSNA, 2020 Online supplemental material is available for this article.
引用
- Wilson MP, Patel D, Murad MH, et al. Diagnostic Performance of MRI in the Detection of Renal Lipid-Poor Angiomyolipomas: A Systematic Review and Meta-Analysis. Radiology. 2020. PMID: 32602827. doi:10.1148/radiol.2020192070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。